NorthView Acquisition Corp. Files Q3 2024 10-Q

TL;DR

NorthView Acquisition Corp. filed its Q3 2024 10-Q. All systems go.

AI Summary

NorthView Acquisition Corp. filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Delaware, is involved in the Surgical & Medical Instruments & Apparatus industry. Its principal executive offices are located at 207 West 25th St, 9th Floor, New York, NY 10001.

Why It Matters

This filing provides an update on NorthView Acquisition Corp.'s financial performance and operational status for the third quarter of 2024, which is crucial for investors to assess the company's current health and future prospects.

Risk Assessment

Risk Level: low — This filing is a standard quarterly report and does not contain immediate red flags or significant new risks.

Key Numbers

• 001-41177 — Commission File Number (Identifies the company's filing with the SEC.)
• 20240930 — Quarterly Period End (Indicates the end date for the financial reporting period.)

Key Players & Entities

• NorthView Acquisition Corp. (company) — Registrant
• September 30, 2024 (date) — Quarterly period end date
• 207 West 25th St, 9th Floor, New York, NY 10001 (location) — Principal executive offices address
• 001-41177 (other) — Commission File Number
• Delaware (location) — State of incorporation

FAQ

Key Financial Figures

• $0.0001 — ange on which registered Common Stock, $0.0001 par value per share NVAC The Nasdaq Sto
• $11.50 — of common stock at an exercise price of $11.50 per whole share NVACW The Nasdaq Stock
• $11.13 — k were redeemed at a per share price of $11.13. In January 2024, $1,565,078 was paid f
• $1,565,078 — share price of $11.13. In January 2024, $1,565,078 was paid from the Trust Account to rede
• $11.78 — k were redeemed at a per share price of $11.78. In October 2024, $595,439 was paid fro
• $595,439 — share price of $11.78. In October 2024, $595,439 was paid from the Trust Account to rede

Filing Documents

• ea0224520-10q_northview.htm (10-Q) — 865KB
• ea022452001ex31-1_northview.htm (EX-31.1) — 15KB
• ea022452001ex31-2_northview.htm (EX-31.2) — 15KB
• ea022452001ex32-1_northview.htm (EX-32.1) — 7KB
• ea022452001ex32-2_northview.htm (EX-32.2) — 7KB
• 0001213900-24-109808.txt ( ) — 5172KB
• nvac-20240930.xsd (EX-101.SCH) — 43KB
• nvac-20240930_cal.xml (EX-101.CAL) — 23KB
• nvac-20240930_def.xml (EX-101.DEF) — 267KB
• nvac-20240930_lab.xml (EX-101.LAB) — 384KB
• nvac-20240930_pre.xml (EX-101.PRE) — 260KB
• ea0224520-10q_northview_htm.xml (XML) — 609KB

Financial Information

Part I. Financial Information 1 Item 1.

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023 1 Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 2 Unaudited Condensed Consolidated Statements of Changes in Stockholders' Deficit for the three and nine months ended September 30, 2024 and 2023 3 Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 4 Notes to Unaudited Condensed Consolidated Financial Statements 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures Regarding Market Risk

Quantitative and Qualitative Disclosures Regarding Market Risk 29 Item 4.

Controls and Procedures

Controls and Procedures 29

Other Information

Part II. Other Information 30 Item 1.

Legal Proceedings

Legal Proceedings 30 Item 1A.

Risk Factors

Risk Factors 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 Item 3. Defaults Upon Senior Securities 31 Item 4. Mine Safety Disclosures 31 Item 5. Other Information 31 Item 6. Exhibits 32

Signatures

Part III. Signatures 33 i PART I. FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements. NORTHVIEW ACQUISITION CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2024 (Unaudited) December 31, 2023 Assets Current Assets: Cash $ 533 $ 4,519 Prepaid expenses and other current assets 38,945 6,750 Prepaid income taxes 47,026 — Cash and marketable securities held in Trust Account 595,439 1,565,078 Total Current Assets 681,943 1,576,347 Cash and marketable securities held in Trust Account 8,101,849 9,308,328 Total Assets $ 8,783,792 $ 10,884,675 Liabilities, Redeemable Common Stock and Stockholders' Deficit Current Liabilities: Accounts payable and accrued expenses $ 726,980 $ 449,114 Advance from Profusa 320,717 — Excise tax payable 1,880,944 1,864,106 Common stock to be redeemed (1) 595,439 1,565,078 Income tax payable — 49,061 Convertible promissory note – related party 1,591,380 944,118 Due to related party 50,000 50,000 Total Current Liabilities 5,165,460 4,921,477 Deferred tax liability — 13,661 Warrant liabilities 652,659 156,639 Total Liabilities 5,818,119 5,091,777 Commitments and Contingencies (Note 6) Common stock subject to possible redemption, 687,519 and 833,469 shares at redemption value of approximately $ 11.84 and $ 11.10 at September 30, 2024 and December 31, 2023, respectively 8,140,935 9,252,208 Stockholders' Deficit: Preferred stock, $ 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding — — Common stock, $ 0.0001 par value; 100,000,000 shares authorized; 5,193,750 shares issued and outstanding at September 30, 2024 and December 31, 2023 (excluding 687,519 and 833,469 shares subject to possible redemption at September 30, 2024 and December 31, 2023, respectively) 519 519 Accumulated deficit ( 5,175,781 ) ( 3,459,829 ) Total Stockholders' Deficit ( 5,175,262 ) ( 3,459,310 ) Total Liabilities, Redeemable Common Stock and Stockholders' Deficit $ 8,783,792 $ 10,884,675 (1) I

View Full Filing

View this 10-Q filing on SEC EDGAR